Gastrointestinal Stent Market Size, Share & Trends | 2027

 

Market Overview

Aging and the accompanying decline of physiological processes has significant effects on the gastrointestinal tract. These physiological changes, along with the long exposure to risk factors, increase the incidence rates of atypical disease manifestations, such as obstructions and tumors in the GI tract. The global population is aging rapidly, owing to reduced birth rates and increasing life expectancy. The demographic trend toward an aging population represents a growing need for the management of disorders, such as GI tract obstructions.

According to the data from World Population Prospects, 2019 revision, by 2050, one in six people in the world will be over age 65 that is 16% of the overall population. In 2018, persons aged 65 or above outnumbered children under five years of age, globally. The number of persons aged 80 years or over is projected to triple, from 143 million in 2019 to 426 million in 2050.

The majority of GI cancers occur in people older than 50. According to the American Society of Clinical Oncology, the average age at the diagnosis of colon cancer in men is 68 and in women is 72. For stomach cancer, the average age is 68, and for rectal cancer, the average age is 63 for both sexes.

Therefore, the rapid increase in geriatric population may result in an exponential increase in GI disorders, which may require stent introduction, which, in turn, is propelling the market growth.

Scope of the Report

As per the scope of the report, gastrointestinal stents are used for the management of obstructive symptoms in the GI tract, which can arise due to diseases of the GI tract, such as malignancies of the stomach, esophagus, duodenum, and pancreas. Read Full Report